Gram-positive bacterial infections
MONDO:0021679Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
Also known as: Gram Positive bacterial infections, Gram-positive bacterial infection, Gramme Positive bacterial infections, bacterial infection, Gram-positive, bacterial infections, Gram Positive, bacterial infections, Gram-positive, bacterial infections, Gramme Positive, infection, Gram-positive bacterial
251 clinical trials for this condition and its sub-types, 7 tagged with Gram-positive bacterial infections itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gram-positive bacterial infections
-
Streptococcal infection 19 trials · 131 incl. sub-types
8 sub-types
- Pneumococcal infection 89 trials · 99 incl. sub-types Sub-types →
- Group B streptococcal infection 9 trials
- Streptococcal sore throat 8 trials
- Impetigo 5 trials Sub-types →
- Erysipelas 1 trial
- Streptococcal toxic-shock syndrome 1 trial
- Scarlet fever 0 trials
- Streptococcal meningitis 0 trials Sub-types →
-
Clostridium infectious disease 48 trials · 96 incl. sub-types
3 sub-types
- Tetanus 43 trials Sub-types →
- Botulism 5 trials Sub-types →
- Infection due to clostridium perfringens 0 trials Sub-types →
-
Bacillaceae infectious disease 1 trial · 20 incl. sub-types
1 sub-type
- Anthrax infection 17 trials · 20 incl. sub-types Sub-types →
-
1 sub-type
- Actinomycosis 0 trials Sub-types →
-
Erysipelothrix infectious disease 0 trials
1 sub-type
-
Infection caused by Bifidobacterium 0 trials
Most studied deeper sub-types
-
New hope for recurring c. diff: which treatment works best?
Disease control Stopped earlyThis study tested three different antibiotic regimens for people with recurrent Clostridium difficile infection (C. diff), a serious gut infection that keeps coming back. The goal was to see if newer drugs like fidaxomicin or a tapered/pulsed course of vancomycin work better than…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Promising c. diff drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested a new drug called REC-3964 to see if it could prevent repeat Clostridioides difficile (C. diff) infections in adults. Only 3 people were enrolled before the trial was stopped early. The goal was to check safety and whether the drug helped people stay infection-f…
Phase 2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New inhaled drug aimed at stubborn lung infection shows promise, but trial halted early
Disease control Stopped earlyThis phase 3 study tested an inhaled form of the antibiotic clofazimine added to standard therapy for people with MAC lung disease that did not respond to previous treatment. The goal was to see if the drug could clear the infection from sputum cultures and improve quality of lif…
Phase 3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Vaccine antibody check: how long does protection last?
Knowledge-focused Stopped earlyThis study followed women who previously received 1 to 3 doses of an experimental Group B Strep (GBS) vaccine. The goal was to see how long their immune antibodies lasted by taking yearly blood samples for 2 to 5 years. No new vaccine or treatment was given—only observation.
Sponsor: Minervax ApS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC